Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 10490 records

$600,000.00

Apr 1, 2012
Description:

Using the zebrafish as a pre-clinical animal tumour model for drug discovery and the evaluation of anti-leukemia agents

Organization: Canadian Institutes of Health Research
Location: Halifax, Nova Scotia, CA B3H 3J5

$290,176.00

Apr 1, 2012
Description:

Early phase clinical trials with the small molecule DCA in Pulmonary Arterial Hypertension

Organization: Canadian Institutes of Health Research
Location: Edmonton, Alberta, CA T6G 2E1

$776,835.00

Apr 1, 2012
Description:

Severe influenza in infants, children and youths: Role of clinical and epidemiologic risk factors

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 1X8

$493,169.00

Apr 1, 2012
Description:

The Role of microRNAs in Renal Cell Carcinoma Pathogenesis and their Clinical Utility as Tumor Markers

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5B 1W8

$110,000.00

Apr 1, 2012
Description:

Ex Vivo IL-10 Gene Therapy in a Pre-Clinical Lung Transplantation Survival Model

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 2C4

$297,244.00

Apr 1, 2012
Description:

Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 2C4

$165,077.00

Apr 1, 2012
Description:

Clinical Outcomes and Cost-Effectiveness of Walk-In Counselling Clinics: A Controlled Study

Organization: Canadian Institutes of Health Research
Location: Waterloo, Ontario, CA N2L 3C5

$347,338.00

Apr 1, 2012
Description:

Strategic configuration of cancer care services based on clinical, demographic and geographic considerations

Organization: Canadian Institutes of Health Research
Location: Vancouver, British Columbia, CA V6T 1Z1

$472,096.00

Apr 1, 2012
Description:

Completion of the Derivation of a Clinical Decision Rule to Predict Mobility Decline among Independent Seniors with Minor Injuries in the Emergency Department (Phase 1B)

Organization: Canadian Institutes of Health Research
Location: Québec, Quebec, CA G1K 7P4

$140,000.00

Apr 1, 2012
Description:

Advancing Tumour Infiltrating Lymphocyte Therapy for Ovarian Cancer to the Clinic

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 2C4